SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO LTD
Overview
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering HEPARIN SODIUM USP.
API / Drug Master Files
SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO LTD holds 1 active (1 total) FDA Type II Drug Master File — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.
- HEPARIN SODIUM USPActive2004-11-17
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to SHENZHEN HEPALINK PHARMACEUTICAL GROUP CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.